Clinical trials recruiting for Anticoagulant Adverse Reaction
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| OAC will be discontinued for the duration of the trial | 1 |
| Rivaroxaban 15 MG | 1 |
| Rivaroxaban 20 MG | 1 |
| Standard-dose rivaroxaban | 1 |
| low-dose rivaroxaban | 1 |
Self-screener
Recruiting trials
- Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC)
- Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrillation
- Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation
Related conditions
Trials recruiting for Anticoagulant Adverse Reaction often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Anticoagulant Adverse Reaction trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.